ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Flood Asks ACCC for Greater Community Effort

February 14, 1975

Rall Says NTP to Put 50-75 Chemicals On Long Term Tests

January 19, 1979

NCI Budget Picture: New Grants Down, No New Center Awards, Many Projects Left Unfunded

December 10, 1976

Letter to the Editor: NCI Should Continue Supporting Research In Special Populations

July 31, 1998

NCI Study Tests Donor T Cells Against Breast Cancer

August 29, 2003

Translucent Walls, Modern Classics Create “Corporate Feel” In Office Suite Occupied By Wife of MD Anderson President DePinho

May 24, 2013